Free Stadium Blanket. Join for Life.

SuPAR Identifies Patients at High Risk of Blood Clot Formation

August 4, 2022

 • 

Read time:

5-15 mins
Blood Clot Red Cells Vein
Presented by Health Lab

Michigan Medicine releases a new study on the link between high-risk blood clot formation and COVID-19. Higher levels of suPAR, a protein that circulates in the blood and originates from immune cells, were associated with an increased risk of blood clot formation in patients hospitalized with COVID-19. Salim Hayek, M.D., medical director of the U-M Frankel Cardiovascular Center Clinics, shares insights from his work with a team of researchers from across the globe and implications for future treatments.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.